OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review

OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME188486FSA
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

OpGen Inc (OPGN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company's clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen's develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Jun 12,2018: OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas for Predicting Antibiotic Resistance in Urine Specimens

May 08,2018: OpGen Announces First Quarter 2018 Financial Results

Apr 19,2018: OpGen Completes Rapid Testing Clinical Trial In Colombia And Expands International Operations

Mar 15,2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results

Mar 13,2018: OpGen Announces Collaborator in Verification Study for Acuitas Test

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

OpGen Inc-Key Facts 6

OpGen Inc-Key Employees 7

OpGen Inc-Key Employee Biographies 8

OpGen Inc-Major Products and Services 9

OpGen Inc-History 10

OpGen Inc-Company Statement 11

OpGen Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

OpGen Inc-Business Description 15

R&D Overview 15

OpGen Inc-Corporate Strategy 16

OpGen Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

OpGen Inc-Strengths 17

OpGen Inc-Weaknesses 18

OpGen Inc-Opportunities 19

OpGen Inc-Threats 20

OpGen Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29

OpGen Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 31

Apr 19, 2018: OpGen Completes Rapid Testing Clinical Trial In Colombia And Expands International Operations 33

Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 34

Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 36

Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 37

Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 38

Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 39

Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 40

Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 42

Jun 15, 2017: OpGen's Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 44

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

OpGen Inc, Performance Chart (2013-2017) 25

OpGen Inc, Ratio Charts 27

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 29

List of Tables

OpGen Inc, Key Facts 6

OpGen Inc, Key Employees 7

OpGen Inc, Key Employee Biographies 8

OpGen Inc, Major Products and Services 9

OpGen Inc, History 10

OpGen Inc, Subsidiaries 13

OpGen Inc, Key Competitors 21

OpGen Inc, Ratios based on current share price 22

OpGen Inc, Annual Ratios 23

OpGen Inc, Annual Ratios (Cont...1) 24

OpGen Inc, Interim Ratios 26

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29

OpGen Inc, Recent Deals Summary 30

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Quest Diagnostics Incorporated - Enterix Colorectal Cancer Screening Test Business


Bio-Reference Laboratories, Inc. - Assets

Bio-Reference Laboratories Inc

Accelerate Diagnostics Inc

OpGen Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com